Archimedic Blog

The prospect of obtaining a new reimbursement code and corresponding coverage for a new medical device is daunting. So much so that many investors simply refuse to pursue medical device opportunities ...

Happy Wednesday to 602 motivated medtech business leaders. Here's one short tip on how to refine your medtech strategy.

In this week's issue, I'm going to break down the #1 thing that prevents medt...

Here are 4 steps on how to clearly define the clinical outcome that compels adoption of your new medical device.

If you are growing a medical device business, a big part of your mission is to impro...

Consider a medical device startup, facing a critical market decision: Should the company go big, aiming for the $1B market out of the gate? Or should the company go small, proving value with an initia...

True story. A medical device manufacturer developed an at-home wearable defibrillator for populations at high risk of sudden cardiac death. This device was intended to be a bridge – worn for approxima...

Clinical use is a significant milestone for most medical device companies. Investors often see this milestone as a significant de-risking activity – one that can come with valuation bumps and subseque...

It’s a critical decision that defines your commercial strategy – but it’s one that is often taken without carefully weighing the pros and cons of each route.

What are the motivations for heading down...

New technology is one of the primary drivers of growth in the medical device industry. Developing new tech can be long, iterative, and expensive -- so it is understandable that companies secure patent...

“You need to show clinical evidence that your medical device provides a benefit.” It's a common request that early medical device innovators hear after they gain regulatory clearance. It’s rational, e...

Many medtech leaders are pressured by investors and others to rapidly achieve regulatory clearance with a product design that is not intended for the market. This is sometimes referred to as a “paper ...

The phrase “proof-of-concept” (POC) is widely used and engrained in the accepted formula of innovation. Engineers, scientists, researchers, and instructors operate under this mantra – fulfilling a hyp...

It’s a critical decision that defines your commercial strategy – one that affects your market time horizon, pricing, marketing claims, distribution strategy, and more. Who pays and why?

It sounds fun...